Galactoside inhibitors of galectins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8703720
APP PUB NO 20120165277A1
SERIAL NO

13266960

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3. The novel compounds are defined by the general formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALECTO BIOTECH AB225 94 LUND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Leffler, Hakon Lund, SE 27 152
Nilsson, Ulf J Lund, SE 4 22
Von, Wachenfeldt Henrik Gothenburg, SE 5 19

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 22, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00